[Cytological examination for determining the therapeutic response of prostatic carcinoma to hormonal therapy (author's transl)]
- PMID: 1189122
- DOI: 10.1159/000279986
[Cytological examination for determining the therapeutic response of prostatic carcinoma to hormonal therapy (author's transl)]
Abstract
51 patients with proven prostatic carcinoma stage B-D underwent control aspiration biopsy after hormonal therapy using the Franzén needle. The malignancies were classified into three grades and the cytological findings were compared with the malignancy grade of the tumor and the clinical course. At the same time the caryopycnotic index, as determined by swabs from the urethral fossa navicularis was measured in order to determine the serum estrogen level. As the result of the anti-androgenic therapy one finds degenerative changes in the tumor cells. The results showed that the poorer the histological differentiation of the tumor, the lesser was the cytological change. Only 6 of 34 patients with a good hormonal effect showed a progression of the tumor, whereas 16 of 17 patients with a poor hormonal effect showed clinical progression. 70% of the cases demonstrated agreement between the clinical course and the caryopycnotic index. No correlation was found between the caryopycnotic index and the histological grade of the tumor.
Similar articles
-
[Carcinoma of the breast under estrogen-treatment for prostatic carcinoma (author's transl)].Urologe A. 1973 Sep;12(5):249-53. Urologe A. 1973. PMID: 4357698 German. No abstract available.
-
[The prognostic significance of cytologic differentiation grades of estrogen-treated prostata carcinoma. Progress control of 496 prostate carcinoma patients treated with estrogen for five years (author's transl)].Urologe A. 1978 Nov;17(6):377-81. Urologe A. 1978. PMID: 726160 German.
-
Prognostic significance of cytological differentiation grading in estrogen-treated prostatic carcinoma diagnosed by fine-needle aspiration biopsy. (Five-year follow-up of 496 patients).Int Urol Nephrol. 1980;12(4):347-54. doi: 10.1007/BF02082472. Int Urol Nephrol. 1980. PMID: 6892030
-
[Effect of tegafur administration combined with hormonal therapy in patients with newly diagnosed stage D prostatic cancer].Hinyokika Kiyo. 1990 Jul;36(7):793-800. Hinyokika Kiyo. 1990. PMID: 2239576 Review. Japanese.
-
Hormonal therapy for stage D cancer of the prostate.West J Med. 1994 Apr;160(4):351-9. West J Med. 1994. PMID: 8023485 Free PMC article. Review.
Cited by
-
The proliferative pattern of the prostatic carcinoma before and under hormonal treatment.Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1976 Dec 9;87(3):311-20. doi: 10.1007/BF00506504. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1976. PMID: 138277 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials